Related Experiment Video
Updated: Jul 4, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Microalbuminuria: risk factor and potential therapeutic target for stroke?
1Stroke Center and Department of Neurology, UCLA Medical Center, Los Angeles, CA 90095, United States. Ovibes@mednet.ucla.edu
Abstract:
Microalbuminuria (MA), a microvascular irregularity of the blood-urine interface within kidney glomeruli, may reflect the renal sign of global endothelial dysfunction, and has been associated with an elevated risk of serious cardiovascular events including stroke. This relationship appears graded, with higher levels of MA being independently associated with a greater magnitude of vascular risk over time. Furthermore, the presence of MA appears to independently predict poorer clinical outcomes following acute stroke. Screening for MA is relatively easy and inexpensive and could be effective in identifying stroke patients at risk for unfavorable outcomes. Reduction of subclinical albuminuria in stroke patients could be a clinically relevant endpoint worthy of pursuit by pharmacological treatment since the antiproteinuric effects of several established therapies appear to parallel better cardiovascular prognosis including better stroke outcomes, among subjects at high vascular risk. This review depicts the compelling epidemiological and clinical evidence relating MA to stroke, and presents the rationale for conducting future studies to assess the role of MA as a potential therapeutic target in persons with, or at risk for stroke.
Insights
Microalbuminuria (MA), a marker of kidney and blood vessel health, is linked to higher stroke risk and worse outcomes. Early screening and treatment targeting MA may improve cardiovascular prognosis in stroke patients.
Area of Science:
- Nephrology
- Cardiology
- Neurology
Background:
- Microalbuminuria (MA) indicates kidney glomerular microvascular dysfunction.
- MA is a potential marker for global endothelial dysfunction.
- MA is associated with increased cardiovascular event risk, particularly stroke.
Purpose of the Study:
- To review evidence linking MA to stroke.
- To explore MA as a predictor of stroke outcomes.
- To present a rationale for investigating MA as a therapeutic target in stroke.
Main Methods:
- Epidemiological data review.
- Clinical evidence synthesis.
- Analysis of existing therapeutic data.
Main Results:
- Higher MA levels correlate with greater vascular risk.
- MA presence independently predicts poorer outcomes post-stroke.
- MA screening is simple, inexpensive, and identifies at-risk patients.
Conclusions:
- MA is a significant risk factor and predictor in stroke.
- Reducing MA may improve cardiovascular prognosis and stroke outcomes.
- Further research is warranted to establish MA as a therapeutic target for stroke prevention and management.
Related Concept Videos
Diabetic Nephropathy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction